Menu

Blog

Jun 15, 2019

First Human Clinical Trial Results on the Anti-Aging Compound, Urolithin A, PUblished

Posted by in categories: biotech/medical, business, life extension

LAUSANNE, Switzerland—(BUSINESS WIRE).

Breakthrough translational science of dietary supplementation with Urolithin A, a pomegranate metabolite, on mitochondrial and cellular health in humans published in the journal Nature Metabolism

Amazentis, an innovative life sciences company pioneering scientific breakthroughs in nutrition to manage health conditions linked to aging, announced today a collaborative publication in Nature Metabolism with scientists at the École Polytechnique Fédérale de Lausanne (EPFL) and the Swiss Institute of Bioinformatics (SIB) demonstrating the Company’s lead product, Urolithin A (UA), is safe, bioavailable and improves mitochondrial and cellular health in humans.

Comments are closed.